Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to MarketBeat Daily Ratings so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.

ALX Oncology (ALXO) SEC Filings & 10K Form

$14.21
-0.45 (-3.07%)
(As of 05/17/2024 08:53 PM ET)

Recent ALX Oncology SEC Filings

DateFilerForm TypeView
05/09/2024
3:10 PM
ALX Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
4:31 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
3:49 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
3:34 PM
ALX Oncology (Subject)
Pons Jaume (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/05/2024
4:37 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:37 PM
ALX Oncology (Subject)
Pons Jaume (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/16/2024
5:24 PM
ALX Oncology (Issuer)
Pinto Shelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Shocking: One AI startup's revenue could surge 4,735% (Ad)

Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.

Click here to discover the AI chip company
02/16/2024
5:03 PM
ALX Oncology (Issuer)
Lettmann Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
5:09 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
5:17 PM
ALX Oncology (Issuer)
Randolph Sophia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
5:21 PM
ALX Oncology (Issuer)
GARCIA PETER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
6:45 PM
ALX Oncology (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G/A
02/14/2024
6:28 PM
ALX Oncology (Subject)
LSV Associates, LLC (Filed by)
Form SC 13D/A
02/09/2024
7:35 AM
ALX Oncology (Subject)
FMR LLC (Filed by)
Form SC 13G/A
10/16/2023
4:15 PM
ALX Oncology (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G
10/13/2023
3:00 PM
ALX Oncology (Subject)
Cormorant Asset Management, LP (Filed by)
Form SC 13G
10/06/2023
5:05 AM
ALX Oncology (Filer)
Form 424B5
10/06/2023
5:06 AM
ALX Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2023
4:21 PM
ALX Oncology (Filer)
Form 424B5
10/04/2023
4:21 PM
ALX Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2023
7:00 AM
ALX Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2023
3:24 PM
ALX Oncology (Issuer)
Lettmann Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2023
11:15 PM
ALX Oncology (Filer)
Form EFFECT
09/08/2023
3:25 PM
ALX Oncology (Filer)
Form 424B3
09/01/2023
3:11 PM
ALX Oncology (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/25/2023
3:44 PM
ALX Oncology (Filer)
Form 424B5
07/07/2023
3:09 PM
ALX Oncology (Issuer)
Pinto Shelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:51 PM
ALX Oncology (Issuer)
Nielsen Jack (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:43 PM
ALX Oncology (Issuer)
Hemrajani Rekha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:46 PM
ALX Oncology (Issuer)
Lettmann Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:30 PM
ALX Oncology (Issuer)
Garland J. Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:32 PM
ALX Oncology (Issuer)
GOODMAN COREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:27 PM
ALX Oncology (Issuer)
Canamasas Itziar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
7:45 AM
ALX Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2023
3:38 PM
ALX Oncology (Issuer)
Randolph Sophia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ALXO) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners